ALBIREO PHARMA, INC. Annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from 2010 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
Albireo Pharma, Inc. quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from 2010 to 2021.
  • Albireo Pharma, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending September 30, 2022 was -$37.8M, a 162% decline year-over-year.
  • Albireo Pharma, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending September 30, 2022 was -$122M, a 141% decline year-over-year.
  • Albireo Pharma, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was -$24.3M, a 80.2% increase from 2020.
  • Albireo Pharma, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2020 was -$123M, a 103% decline from 2019.
  • Albireo Pharma, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2019 was -$60.6M, a 41.4% decline from 2018.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Annual (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$24.3M +$98.4M +80.2% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-01
2020 -$123M -$62.1M -103% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 -$60.6M -$17.7M -41.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 -$42.8M -$17.9M -71.9% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-02
2017 -$24.9M -$9.25M -59.1% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 -$15.7M -$9.24M -144% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-27
2015 -$6.42M Jan 1, 2015 Dec 31, 2015 10-K 2017-03-27
2012 -$20.7M -$10.2M -95.9% Oct 1, 2011 Sep 30, 2012 10-K 2012-12-21
2011 -$10.6M +$27.7M +72.3% Oct 1, 2010 Sep 30, 2011 10-K 2012-12-21
2010 -$38.3M Oct 1, 2009 Sep 30, 2010 10-K 2012-12-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.